RISK FACTOR, CARDIOVASCULAR
Clinical trials for RISK FACTOR, CARDIOVASCULAR explained in plain language.
Never miss a new study
Get alerted when new RISK FACTOR, CARDIOVASCULAR trials appear
Sign up with your email to follow new studies for RISK FACTOR, CARDIOVASCULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart shield for chemo: carvedilol may guard against toxicity
Disease control CompletedThis early-phase study tested whether the heart medication carvedilol could safely prevent heart damage in breast cancer patients receiving chemotherapy with doxorubicin and/or trastuzumab. Researchers assigned 68 women to either usual care or carvedilol based on their risk of he…
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 26, 2026 09:37 UTC
-
CAR T-Cell therapy: hidden heart risks revealed in new study
Knowledge-focused CompletedThis study followed 44 adults with leukemia or lymphoma who received CAR T-cell therapy to see how their hearts were affected. Researchers used heart scans, blood tests, and quality-of-life surveys to track heart function over time. The goal was to find out how often heart proble…
Matched conditions: RISK FACTOR, CARDIOVASCULAR
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC